IP-10 detection in urine is associated with lung diseases View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2010-11-22

AUTHORS

Angela Cannas, Ludovica Calvo, Teresa Chiacchio, Gilda Cuzzi, Valentina Vanini, Francesco N Lauria, Luigia Pucci, Enrico Girardi, Delia Goletti

ABSTRACT

BACKGROUND: Blood cytokines and chemokines have been proposed as biomarkers for tuberculosis (TB). Recently, some immune mediators found in the urine of patients with renal dysfunctions have also been suggested as potential biomarkers. Finding biomarkers for TB in urine would present several advantages over blood in terms of collection and safety. The objective of this study was to investigate the presence of cytokines and chemokines in the urine of patients with pulmonary TB at the time of diagnosis. In a subgroup, the evaluation was also performed during TB treatment and at therapy completion. Patients with lung diseases other than TB, and healthy subjects were also enrolled. METHODS: Urine samples from 138 individuals, after exclusion of renal dysfunctions, were collected during an 18 month-period. Among them, 58 received a diagnosis of pulmonary TB, 28 resulted having lung diseases other than TB, and 34 were healthy subjects. Moreover, 18 TB patients, 9 of whom were tested 2 months after AFB smear sputum reversion and 9 of whom were cured of TB were also included. Cytokines and chemokines in urine were evaluated using a Cytometric-Bead-Array-Flex-Set. IP-10 detection in 49 subjects was also carried out in parallel by using an Enzyme Linked ImmunoSorbent Assay (ELISA). RESULTS: IFN-γ, TNF-α, IL-2, IL-8, MIP-1α, MIP-1β and RANTES were poorly detected in all urine samples. Conversely, IP-10 was consistently detected in urine and its level was significantly increased in patients with lung disease compared to healthy subjects (p < 0.001). Increased IP-10 levels were found in both pulmonary TB and lung diseases other than TB. Moreover lower IP-10 levels were found in cured-TB patients compared to the levels at the time of diagnosis, and this difference was close to significance (p = 0.06). Interestingly, we demonstrated a significant correlation between the data obtained by flow cytometry and ELISA (r² 0.82, p < 0.0001). CONCLUSIONS: IP-10, in contrast to IFN-γ, TNF-α, IL-2, IL-8, MIP-1α, MIP-1β and RANTES, is detectable in the urine of patients with pulmonary diseases in the absence of renal dysfunctions. Moreover, the IP-10 level in cured-TB patients is comparable to that found in healthy subjects. More studies are needed to further investigate the clinical utility of these findings. More... »

PAGES

333-333

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1471-2334-10-333

DOI

http://dx.doi.org/10.1186/1471-2334-10-333

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1052844800

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/21092156


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemokine CXCL10", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemokines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytokines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Enzyme-Linked Immunosorbent Assay", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Flow Cytometry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lung Diseases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tuberculosis, Pulmonary", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Epidemiology and Preclinical Research, L. Spallanzani National Institute for Infectious Diseases (INMI), Rome, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Epidemiology and Preclinical Research, L. Spallanzani National Institute for Infectious Diseases (INMI), Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cannas", 
        "givenName": "Angela", 
        "id": "sg:person.0622436115.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0622436115.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Epidemiology and Preclinical Research, L. Spallanzani National Institute for Infectious Diseases (INMI), Rome, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Epidemiology and Preclinical Research, L. Spallanzani National Institute for Infectious Diseases (INMI), Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Calvo", 
        "givenName": "Ludovica", 
        "id": "sg:person.0737103324.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0737103324.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Translational Research Unit, Department of Epidemiology and Preclinical Research, INMI, Rome, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Translational Research Unit, Department of Epidemiology and Preclinical Research, INMI, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chiacchio", 
        "givenName": "Teresa", 
        "id": "sg:person.01250107466.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01250107466.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Translational Research Unit, Department of Epidemiology and Preclinical Research, INMI, Rome, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Translational Research Unit, Department of Epidemiology and Preclinical Research, INMI, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cuzzi", 
        "givenName": "Gilda", 
        "id": "sg:person.0604346205.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0604346205.97"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Translational Research Unit, Department of Epidemiology and Preclinical Research, INMI, Rome, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Translational Research Unit, Department of Epidemiology and Preclinical Research, INMI, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vanini", 
        "givenName": "Valentina", 
        "id": "sg:person.0650313551.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0650313551.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Pneumology Unit, Health Department, INMI, Rome, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Pneumology Unit, Health Department, INMI, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lauria", 
        "givenName": "Francesco N", 
        "id": "sg:person.01050065003.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050065003.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Clinical Biochemistry and Pharmacology Laboratory, INMI, Rome, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Clinical Biochemistry and Pharmacology Laboratory, INMI, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pucci", 
        "givenName": "Luigia", 
        "id": "sg:person.0766710005.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0766710005.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Epidemiology and Preclinical Research, L. Spallanzani National Institute for Infectious Diseases (INMI), Rome, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Epidemiology and Preclinical Research, L. Spallanzani National Institute for Infectious Diseases (INMI), Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Girardi", 
        "givenName": "Enrico", 
        "id": "sg:person.01222655205.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01222655205.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Translational Research Unit, Department of Epidemiology and Preclinical Research, INMI, Rome, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Translational Research Unit, Department of Epidemiology and Preclinical Research, INMI, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Goletti", 
        "givenName": "Delia", 
        "id": "sg:person.01200446072.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01200446072.99"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/pl00007615", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001543359", 
          "https://doi.org/10.1007/pl00007615"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12016-010-8197-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050483079", 
          "https://doi.org/10.1007/s12016-010-8197-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02715666", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022119750", 
          "https://doi.org/10.1007/bf02715666"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/ar1029", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019499476", 
          "https://doi.org/10.1186/ar1029"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/315672a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006952253", 
          "https://doi.org/10.1038/315672a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1020554817047", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012368601", 
          "https://doi.org/10.1023/a:1020554817047"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2010-11-22", 
    "datePublishedReg": "2010-11-22", 
    "description": "BACKGROUND: Blood cytokines and chemokines have been proposed as biomarkers for tuberculosis (TB). Recently, some immune mediators found in the urine of patients with renal dysfunctions have also been suggested as potential biomarkers. Finding biomarkers for TB in urine would present several advantages over blood in terms of collection and safety. The objective of this study was to investigate the presence of cytokines and chemokines in the urine of patients with pulmonary TB at the time of diagnosis. In a subgroup, the evaluation was also performed during TB treatment and at therapy completion. Patients with lung diseases other than TB, and healthy subjects were also enrolled.\nMETHODS: Urine samples from 138 individuals, after exclusion of renal dysfunctions, were collected during an 18 month-period. Among them, 58 received a diagnosis of pulmonary TB, 28 resulted having lung diseases other than TB, and 34 were healthy subjects. Moreover, 18 TB patients, 9 of whom were tested 2 months after AFB smear sputum reversion and 9 of whom were cured of TB were also included. Cytokines and chemokines in urine were evaluated using a Cytometric-Bead-Array-Flex-Set. IP-10 detection in 49 subjects was also carried out in parallel by using an Enzyme Linked ImmunoSorbent Assay (ELISA).\nRESULTS: IFN-\u03b3, TNF-\u03b1, IL-2, IL-8, MIP-1\u03b1, MIP-1\u03b2 and RANTES were poorly detected in all urine samples. Conversely, IP-10 was consistently detected in urine and its level was significantly increased in patients with lung disease compared to healthy subjects (p < 0.001). Increased IP-10 levels were found in both pulmonary TB and lung diseases other than TB. Moreover lower IP-10 levels were found in cured-TB patients compared to the levels at the time of diagnosis, and this difference was close to significance (p = 0.06). Interestingly, we demonstrated a significant correlation between the data obtained by flow cytometry and ELISA (r\u00b2 0.82, p < 0.0001).\nCONCLUSIONS: IP-10, in contrast to IFN-\u03b3, TNF-\u03b1, IL-2, IL-8, MIP-1\u03b1, MIP-1\u03b2 and RANTES, is detectable in the urine of patients with pulmonary diseases in the absence of renal dysfunctions. Moreover, the IP-10 level in cured-TB patients is comparable to that found in healthy subjects. More studies are needed to further investigate the clinical utility of these findings.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/1471-2334-10-333", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1024946", 
        "issn": [
          "1471-2334"
        ], 
        "name": "BMC Infectious Diseases", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "10"
      }
    ], 
    "keywords": [
      "IP-10 levels", 
      "urine of patients", 
      "Enzyme Linked Immunosorbent Assay", 
      "IP-10 detection", 
      "time of diagnosis", 
      "lung disease", 
      "renal dysfunction", 
      "pulmonary tuberculosis", 
      "healthy subjects", 
      "MIP-1\u03b2", 
      "MIP-1\u03b1", 
      "IP-10", 
      "IL-8", 
      "IL-2", 
      "lower IP-10 levels", 
      "urine samples", 
      "presence of cytokines", 
      "Linked Immunosorbent Assay", 
      "TB patients", 
      "blood cytokines", 
      "TB treatment", 
      "therapy completion", 
      "immune mediators", 
      "pulmonary disease", 
      "clinical utility", 
      "patients", 
      "potential biomarkers", 
      "tuberculosis", 
      "flow cytometry", 
      "disease", 
      "cytometric beads", 
      "chemokines", 
      "dysfunction", 
      "immunosorbent assay", 
      "cytokines", 
      "urine", 
      "diagnosis", 
      "biomarkers", 
      "more studies", 
      "significant correlation", 
      "RANTES", 
      "IFN", 
      "TNF", 
      "subjects", 
      "levels", 
      "blood", 
      "months", 
      "cytometry", 
      "subgroups", 
      "treatment", 
      "mediators", 
      "study", 
      "safety", 
      "assays", 
      "findings", 
      "AFB", 
      "individuals", 
      "completion", 
      "samples", 
      "absence", 
      "differences", 
      "significance", 
      "evaluation", 
      "detection", 
      "time", 
      "contrast", 
      "correlation", 
      "exclusion", 
      "utility", 
      "presence", 
      "objective", 
      "reversion", 
      "data", 
      "collection", 
      "parallel", 
      "terms", 
      "advantages", 
      "terms of collection", 
      "set", 
      "sputum reversion", 
      "Array-Flex", 
      "cured-TB patients"
    ], 
    "name": "IP-10 detection in urine is associated with lung diseases", 
    "pagination": "333-333", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1052844800"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1471-2334-10-333"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "21092156"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1471-2334-10-333", 
      "https://app.dimensions.ai/details/publication/pub.1052844800"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:21", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_504.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/1471-2334-10-333"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1471-2334-10-333'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1471-2334-10-333'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1471-2334-10-333'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1471-2334-10-333'


 

This table displays all metadata directly associated to this object as RDF triples.

285 TRIPLES      22 PREDICATES      128 URIs      114 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1471-2334-10-333 schema:about N018255a7b53d4959bf7552b5d48507d5
2 N01e50eefd7564194a7d807d02dd4ce28
3 N1724fcc8bdd547fea0cf96a1525985f6
4 N180ec5710f714b4eb13433c961c106b9
5 N1da8705861e642aba408612edd210f48
6 N1e62c41f0b604899ab6d5eddb5aa5eb5
7 N50789164e259437e8061312c02570105
8 N72c6f4e5c88c426bbce805a69c31edb0
9 N87885efff8914078ad1feb2a6f9733eb
10 N8da771d7ef9c43689d4887742582da30
11 Na8a9bc7725c74feab77e043222c0fc2c
12 Nbb88cd21a7e04389aa41c15d668caa31
13 Ndfc77f94029c4084be7b4c0a41e10f55
14 Nec07813f09624684b7b3a9095f005590
15 anzsrc-for:11
16 anzsrc-for:1103
17 schema:author Nd258c6d809ec4f2ca0eb8d9630593c12
18 schema:citation sg:pub.10.1007/bf02715666
19 sg:pub.10.1007/pl00007615
20 sg:pub.10.1007/s12016-010-8197-z
21 sg:pub.10.1023/a:1020554817047
22 sg:pub.10.1038/315672a0
23 sg:pub.10.1186/ar1029
24 schema:datePublished 2010-11-22
25 schema:datePublishedReg 2010-11-22
26 schema:description BACKGROUND: Blood cytokines and chemokines have been proposed as biomarkers for tuberculosis (TB). Recently, some immune mediators found in the urine of patients with renal dysfunctions have also been suggested as potential biomarkers. Finding biomarkers for TB in urine would present several advantages over blood in terms of collection and safety. The objective of this study was to investigate the presence of cytokines and chemokines in the urine of patients with pulmonary TB at the time of diagnosis. In a subgroup, the evaluation was also performed during TB treatment and at therapy completion. Patients with lung diseases other than TB, and healthy subjects were also enrolled. METHODS: Urine samples from 138 individuals, after exclusion of renal dysfunctions, were collected during an 18 month-period. Among them, 58 received a diagnosis of pulmonary TB, 28 resulted having lung diseases other than TB, and 34 were healthy subjects. Moreover, 18 TB patients, 9 of whom were tested 2 months after AFB smear sputum reversion and 9 of whom were cured of TB were also included. Cytokines and chemokines in urine were evaluated using a Cytometric-Bead-Array-Flex-Set. IP-10 detection in 49 subjects was also carried out in parallel by using an Enzyme Linked ImmunoSorbent Assay (ELISA). RESULTS: IFN-γ, TNF-α, IL-2, IL-8, MIP-1α, MIP-1β and RANTES were poorly detected in all urine samples. Conversely, IP-10 was consistently detected in urine and its level was significantly increased in patients with lung disease compared to healthy subjects (p < 0.001). Increased IP-10 levels were found in both pulmonary TB and lung diseases other than TB. Moreover lower IP-10 levels were found in cured-TB patients compared to the levels at the time of diagnosis, and this difference was close to significance (p = 0.06). Interestingly, we demonstrated a significant correlation between the data obtained by flow cytometry and ELISA (r² 0.82, p < 0.0001). CONCLUSIONS: IP-10, in contrast to IFN-γ, TNF-α, IL-2, IL-8, MIP-1α, MIP-1β and RANTES, is detectable in the urine of patients with pulmonary diseases in the absence of renal dysfunctions. Moreover, the IP-10 level in cured-TB patients is comparable to that found in healthy subjects. More studies are needed to further investigate the clinical utility of these findings.
27 schema:genre article
28 schema:inLanguage en
29 schema:isAccessibleForFree true
30 schema:isPartOf N60ddbfc7b52d464aa23d9a9aa20b5886
31 Ndd3270db385b42eb8184d8fa745df634
32 sg:journal.1024946
33 schema:keywords AFB
34 Array-Flex
35 Enzyme Linked Immunosorbent Assay
36 IFN
37 IL-2
38 IL-8
39 IP-10
40 IP-10 detection
41 IP-10 levels
42 Linked Immunosorbent Assay
43 MIP-1α
44 MIP-1β
45 RANTES
46 TB patients
47 TB treatment
48 TNF
49 absence
50 advantages
51 assays
52 biomarkers
53 blood
54 blood cytokines
55 chemokines
56 clinical utility
57 collection
58 completion
59 contrast
60 correlation
61 cured-TB patients
62 cytokines
63 cytometric beads
64 cytometry
65 data
66 detection
67 diagnosis
68 differences
69 disease
70 dysfunction
71 evaluation
72 exclusion
73 findings
74 flow cytometry
75 healthy subjects
76 immune mediators
77 immunosorbent assay
78 individuals
79 levels
80 lower IP-10 levels
81 lung disease
82 mediators
83 months
84 more studies
85 objective
86 parallel
87 patients
88 potential biomarkers
89 presence
90 presence of cytokines
91 pulmonary disease
92 pulmonary tuberculosis
93 renal dysfunction
94 reversion
95 safety
96 samples
97 set
98 significance
99 significant correlation
100 sputum reversion
101 study
102 subgroups
103 subjects
104 terms
105 terms of collection
106 therapy completion
107 time
108 time of diagnosis
109 treatment
110 tuberculosis
111 urine
112 urine of patients
113 urine samples
114 utility
115 schema:name IP-10 detection in urine is associated with lung diseases
116 schema:pagination 333-333
117 schema:productId N48ccccbffa5848ae977128b6d0755f19
118 N729fde1cd04a41b49c4522d2ad83f5bd
119 N8a53fbb676b3423f8fe81326fe34ddcf
120 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052844800
121 https://doi.org/10.1186/1471-2334-10-333
122 schema:sdDatePublished 2022-01-01T18:21
123 schema:sdLicense https://scigraph.springernature.com/explorer/license/
124 schema:sdPublisher N79c68fd34bca4aa7b440d35993cd9d48
125 schema:url https://doi.org/10.1186/1471-2334-10-333
126 sgo:license sg:explorer/license/
127 sgo:sdDataset articles
128 rdf:type schema:ScholarlyArticle
129 N018255a7b53d4959bf7552b5d48507d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Adult
131 rdf:type schema:DefinedTerm
132 N01e50eefd7564194a7d807d02dd4ce28 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Chemokines
134 rdf:type schema:DefinedTerm
135 N05b266d6baa8484e886f79bfa752c7f9 rdf:first sg:person.0766710005.24
136 rdf:rest N4837d62b6a384e10a4a94f195f8a4dc4
137 N165db9212c734f5aafae2ba2ba149834 rdf:first sg:person.0737103324.09
138 rdf:rest N919a5a4e26884434a8e81992b1eeb075
139 N1724fcc8bdd547fea0cf96a1525985f6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Female
141 rdf:type schema:DefinedTerm
142 N180ec5710f714b4eb13433c961c106b9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Enzyme-Linked Immunosorbent Assay
144 rdf:type schema:DefinedTerm
145 N18fef283fa38461d9a9b2ee72dcbded1 rdf:first sg:person.01200446072.99
146 rdf:rest rdf:nil
147 N1da8705861e642aba408612edd210f48 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Adolescent
149 rdf:type schema:DefinedTerm
150 N1e62c41f0b604899ab6d5eddb5aa5eb5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Lung Diseases
152 rdf:type schema:DefinedTerm
153 N3dc10bf74d6240fdb9341edaedf36690 rdf:first sg:person.0650313551.19
154 rdf:rest N6c4ff9a855644636984f477f65473379
155 N4837d62b6a384e10a4a94f195f8a4dc4 rdf:first sg:person.01222655205.82
156 rdf:rest N18fef283fa38461d9a9b2ee72dcbded1
157 N48ccccbffa5848ae977128b6d0755f19 schema:name pubmed_id
158 schema:value 21092156
159 rdf:type schema:PropertyValue
160 N50789164e259437e8061312c02570105 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Cytokines
162 rdf:type schema:DefinedTerm
163 N60ddbfc7b52d464aa23d9a9aa20b5886 schema:volumeNumber 10
164 rdf:type schema:PublicationVolume
165 N6c4ff9a855644636984f477f65473379 rdf:first sg:person.01050065003.28
166 rdf:rest N05b266d6baa8484e886f79bfa752c7f9
167 N729fde1cd04a41b49c4522d2ad83f5bd schema:name dimensions_id
168 schema:value pub.1052844800
169 rdf:type schema:PropertyValue
170 N72c6f4e5c88c426bbce805a69c31edb0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Flow Cytometry
172 rdf:type schema:DefinedTerm
173 N79c68fd34bca4aa7b440d35993cd9d48 schema:name Springer Nature - SN SciGraph project
174 rdf:type schema:Organization
175 N87885efff8914078ad1feb2a6f9733eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Chemokine CXCL10
177 rdf:type schema:DefinedTerm
178 N8a53fbb676b3423f8fe81326fe34ddcf schema:name doi
179 schema:value 10.1186/1471-2334-10-333
180 rdf:type schema:PropertyValue
181 N8da771d7ef9c43689d4887742582da30 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Tuberculosis, Pulmonary
183 rdf:type schema:DefinedTerm
184 N919a5a4e26884434a8e81992b1eeb075 rdf:first sg:person.01250107466.00
185 rdf:rest Nf38e93fd56dd4bf29a03a1d822fdb528
186 Na8a9bc7725c74feab77e043222c0fc2c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Biomarkers
188 rdf:type schema:DefinedTerm
189 Nbb88cd21a7e04389aa41c15d668caa31 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Young Adult
191 rdf:type schema:DefinedTerm
192 Nd258c6d809ec4f2ca0eb8d9630593c12 rdf:first sg:person.0622436115.66
193 rdf:rest N165db9212c734f5aafae2ba2ba149834
194 Ndd3270db385b42eb8184d8fa745df634 schema:issueNumber 1
195 rdf:type schema:PublicationIssue
196 Ndfc77f94029c4084be7b4c0a41e10f55 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
197 schema:name Male
198 rdf:type schema:DefinedTerm
199 Nec07813f09624684b7b3a9095f005590 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
200 schema:name Humans
201 rdf:type schema:DefinedTerm
202 Nf38e93fd56dd4bf29a03a1d822fdb528 rdf:first sg:person.0604346205.97
203 rdf:rest N3dc10bf74d6240fdb9341edaedf36690
204 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
205 schema:name Medical and Health Sciences
206 rdf:type schema:DefinedTerm
207 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
208 schema:name Clinical Sciences
209 rdf:type schema:DefinedTerm
210 sg:journal.1024946 schema:issn 1471-2334
211 schema:name BMC Infectious Diseases
212 schema:publisher Springer Nature
213 rdf:type schema:Periodical
214 sg:person.01050065003.28 schema:affiliation grid-institutes:None
215 schema:familyName Lauria
216 schema:givenName Francesco N
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050065003.28
218 rdf:type schema:Person
219 sg:person.01200446072.99 schema:affiliation grid-institutes:None
220 schema:familyName Goletti
221 schema:givenName Delia
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01200446072.99
223 rdf:type schema:Person
224 sg:person.01222655205.82 schema:affiliation grid-institutes:None
225 schema:familyName Girardi
226 schema:givenName Enrico
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01222655205.82
228 rdf:type schema:Person
229 sg:person.01250107466.00 schema:affiliation grid-institutes:None
230 schema:familyName Chiacchio
231 schema:givenName Teresa
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01250107466.00
233 rdf:type schema:Person
234 sg:person.0604346205.97 schema:affiliation grid-institutes:None
235 schema:familyName Cuzzi
236 schema:givenName Gilda
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0604346205.97
238 rdf:type schema:Person
239 sg:person.0622436115.66 schema:affiliation grid-institutes:None
240 schema:familyName Cannas
241 schema:givenName Angela
242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0622436115.66
243 rdf:type schema:Person
244 sg:person.0650313551.19 schema:affiliation grid-institutes:None
245 schema:familyName Vanini
246 schema:givenName Valentina
247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0650313551.19
248 rdf:type schema:Person
249 sg:person.0737103324.09 schema:affiliation grid-institutes:None
250 schema:familyName Calvo
251 schema:givenName Ludovica
252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0737103324.09
253 rdf:type schema:Person
254 sg:person.0766710005.24 schema:affiliation grid-institutes:None
255 schema:familyName Pucci
256 schema:givenName Luigia
257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0766710005.24
258 rdf:type schema:Person
259 sg:pub.10.1007/bf02715666 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022119750
260 https://doi.org/10.1007/bf02715666
261 rdf:type schema:CreativeWork
262 sg:pub.10.1007/pl00007615 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001543359
263 https://doi.org/10.1007/pl00007615
264 rdf:type schema:CreativeWork
265 sg:pub.10.1007/s12016-010-8197-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1050483079
266 https://doi.org/10.1007/s12016-010-8197-z
267 rdf:type schema:CreativeWork
268 sg:pub.10.1023/a:1020554817047 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012368601
269 https://doi.org/10.1023/a:1020554817047
270 rdf:type schema:CreativeWork
271 sg:pub.10.1038/315672a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006952253
272 https://doi.org/10.1038/315672a0
273 rdf:type schema:CreativeWork
274 sg:pub.10.1186/ar1029 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019499476
275 https://doi.org/10.1186/ar1029
276 rdf:type schema:CreativeWork
277 grid-institutes:None schema:alternateName Clinical Biochemistry and Pharmacology Laboratory, INMI, Rome, Italy
278 Department of Epidemiology and Preclinical Research, L. Spallanzani National Institute for Infectious Diseases (INMI), Rome, Italy
279 Pneumology Unit, Health Department, INMI, Rome, Italy
280 Translational Research Unit, Department of Epidemiology and Preclinical Research, INMI, Rome, Italy
281 schema:name Clinical Biochemistry and Pharmacology Laboratory, INMI, Rome, Italy
282 Department of Epidemiology and Preclinical Research, L. Spallanzani National Institute for Infectious Diseases (INMI), Rome, Italy
283 Pneumology Unit, Health Department, INMI, Rome, Italy
284 Translational Research Unit, Department of Epidemiology and Preclinical Research, INMI, Rome, Italy
285 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...